Alteration of Fatty Infiltration Grades of the Liver in Sonography as an Outcome of Cholecystectomy
Introduction: Recent studies have not only reported that non-alcoholic fatty liver disease may be associated with cholecystectomy but also emphasized that cholecystectomy may be a risk factor for the accumulation of fat in the liver. In light of this information in the literature, in the present study, we compared the sonographic fatty infiltration grades of patients who had undergone cholecystectomy using laboratory findings obtained be fore an d a f ter the operation.
Objective: Fifty-nine cases whose almost complete laboratory and sonographic data were available were included in the study. Patients were divided into three groups according to the preoperative period and postoperative follow-up periods as 3 months and 6-12 months.
Results: In both groups, there was a statistically significant difference between the preoperative and postoperative steatosis and ultrasound (US) fatty infiltration grades (p<0.001). However, there were no statistically significant differences between the preoperative and two postoperative follow-up periods of US fatty liver grades alteration (p=0.650). The hepatic steatosis index had a significant correlation with steatosis and US fatty infiltration grades (Spearman’s correlation rho=0.319 and rho=0.361, respectively, p<0.001).
Conclusion: Cholecystectomy may lead to an increase in the level of fatty infiltration of the liver in the follow-up sonography, which may occur over a certain period of time through adaptive processes. Early postoperative US imaging for the purpose of hepatosteatosis follow-up is not necessary.
1. Benedict M, Zhang X. Non-alcoholic fatty liver disease: An expanded review. World J Hepatol 2017;9:715–732. [CrossRef]
2. Bellentani S. The epidemiology of non-alcoholic fatty liver disease. Liver Int 2017;37:81–84. [CrossRef]
3. Cortés V, Quezada N, Uribe S, Arrese M, Nervi F. Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese Hispanic patients: a pilot study. Lipids Health Dis 2017;16:129. [CrossRef]
4. Calzadilla Bertot L, Adams LA. The Natural Course of Non-Alcoholic Fatty Liver Disease. Int J Mol Sci 2016;17:E774. [CrossRef]
5. Patel V, Sanyal AJ, Sterling R. Clinical Presentation and Patient Evaluation in Nonalcoholic Fatty Liver Disease. Clin Liver Dis 2016;20:277–92. [CrossRef]
6. Lee SS, Park SH. Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroenterol 2014;20:7392–402. [CrossRef]
7. Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol 2015;62:47–64. [CrossRef]
8. Dietrich P, Hellerbrand C. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Pract Res Clin Gastroenterol 2014;28:637–53. [CrossRef]
9. Ahmed MH, Ali A. Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first? Scand J Gastroenterol 2014;49:521–7. [CrossRef]
10. Kwak MS, Kim D, Chung GE, Kim W, Kim YJ, Yoon JH. Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asianpopulation. World J Gastroenterol 2015;21:6287–95. [CrossRef]
11. Yun S, Choi D, Lee KG, Kim HJ, Kang BK, Kim H, et al. Cholecystectomy Causes Ultrasound Evidence of Increased Hepatic Steatosis. World J Surg 2016;40:1412–21. [CrossRef]
12. Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis 2010;42:503–8. [CrossRef]
13. Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E, et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011;343:6891.
14. Ruhl CE, Everhart JE. Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population. Am J Gastroenterol 2013;108:952–8. [CrossRef]
15. Shen C, Wu X, Xu C, Yu C, Chen P, Li Y. Association of cholecystectomy with metabolic syndrome in a Chinese population. PLoS One 2014;9:e88189. [CrossRef]
16. Koller T, Kollerova J, Hlavaty T, Huorka M, Payer J. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. Scand J Gastroenterol 2012;47:197– 203. [CrossRef]
17. Wang DQ, Lee SP. Physical chemistry of intestinal absorption of biliary cholesterol in mice. Hepatology 2008;48:177–85.
18. Almond HR, Vlahcevic ZR, Bell CC Jr, Gregory DH, Swell L. Bile acid pools, kinetics and biliary lipid composition before and after cholecystectomy. N Engl J Med 1973;289:1213–6. [CrossRef]
19. Shaffer EA, Small DM. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity. J Clin Invest 1977;59:828–40. [CrossRef]
20. Roda E, Aldini R, Mazzella G, Roda A, Sama C, Festi D, et al. Enterohepatic circulation of bile acids after cholecystectomy. Gut 1978;19:640–9. [CrossRef]
21. Eren F, Kurt R, Ermis F, Atug O, Imeryuz N, Yilmaz Y. Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease. Clin Biochem 2012;45:655–8. [CrossRef]